Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK

Author： Dewilde S.   Verdian L.   MacLaine G. D. H.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.25, Iss.8, 2009-08, pp. : 2007-2019

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implantable Intrathecal Drug Delivery Systems

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 2, 2015-02 ,pp. : 150-156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intrathecal Therapy for Chronic Pain

By  

Stereotactic and Functional Neurosurgery, Vol. 77, Iss. 1-4, 2002-10 ,pp. : 156-158

Karger

Access to resources Recommend Favorite

Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain

By Reinhold Thomas  

The European Journal of Health Economics, Vol. 9, Iss. 3, 2008-08 ,pp. : 209-219

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)

By  

PAIN PRACTICE, Vol. 18, Iss. 2, 2018-02 ,pp. : 230-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ziconotide Trialing by Intrathecal Bolus Injections: An Open‐Label Non‐Randomized Clinical Trial in Postoperative/Posttraumatic Neuropathic Pain Patients Refractory to Conventional Treatment

By  

NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, Vol. 18, Iss. 5, 2015-07 ,pp. : 404-413

John Wiley & Sons Inc

Access to resources Recommend Favorite